In January of 2020, the U.S. Federal Government issued final rules fully implementing the new powers granted to the Committee on Foreign Investment in the United States (CFIUS). Effective February 13, 2020, the Committee started to exercise its expanded ability to review the national security implications of more foreign investments - in particular companies with ‘novel or advanced technology’ including biotechnology, artificial intelligence, robotics, quantum computing, and advanced materials. New mandatory filing rules are now in place, and the Committee’s new enforcement team – charged with finding unfiled cases within CFIUS’s jurisdiction – is now bringing in far more cases than ever before.
In this webinar, we’ll review:
• Basics on CFIUS and FIRRMA
• What were the effects seen during the CFIUS 15-month pilot program?
• What types of investments are subject to CFIUS review under the new rules?
• Under the new rules, what questions need to be answered to understand the CFIUS implications of their transaction?
• What types of businesses and investments have been the subject of CFIUS attention since the establishment of the enforcement team?
• How could all of these changes affect investments by non-U.S. investment sources?
• What does this mean for university startups?
• What should we expect from CFIUS going forward?
Our panelists will be:
Stephen Heifetz, Partner, Wilson Sonsini Goodrich & Rosati
Joshua Gruenspecht, Partner, Wilson Sonsini Goodrich & Rosati
This is a follow up to the previous OUP webinar held in April 2019 - CFIUS Pilot Program: Implications for Foreign (and U.S.) Investments in Startup Companies.